» Articles » PMID: 23142051

Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-dependent Melanoma Metastasis and Angiogenesis

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2012 Nov 13
PMID 23142051
Citations 217
Authors
Affiliations
Soon will be listed here.
Abstract

Through in vivo selection of human cancer cell populations, we uncover a convergent and cooperative miRNA network that drives melanoma metastasis. We identify miR-1908, miR-199a-5p, and miR-199a-3p as endogenous promoters of metastatic invasion, angiogenesis, and colonization in melanoma. These miRNAs convergently target apolipoprotein E (ApoE) and the heat shock factor DNAJA4. Cancer-secreted ApoE suppresses invasion and metastatic endothelial recruitment (MER) by engaging melanoma cell LRP1 and endothelial cell LRP8 receptors, respectively, while DNAJA4 promotes ApoE expression. Expression levels of these miRNAs and ApoE correlate with human metastatic progression outcomes. Treatment of cells with locked nucleic acids (LNAs) targeting these miRNAs inhibits metastasis to multiple organs, and therapeutic delivery of these LNAs strongly suppresses melanoma metastasis. We thus identify miRNAs with dual cell-intrinsic/cell-extrinsic roles in cancer, reveal convergent cooperativity in a metastatic miRNA network, identify ApoE as an anti-angiogenic and metastasis-suppressive factor, and uncover multiple prognostic miRNAs with synergistic combinatorial therapeutic potential in melanoma.

Citing Articles

V474I germline variant drives breast cancer metastasis.

Wang H, Shao Z Life Metab. 2025; 4(1):loae041.

PMID: 39872986 PMC: 11770811. DOI: 10.1093/lifemeta/loae041.


Single-cell RNA-sequencing and spatial transcriptomic analysis reveal a distinct population of APOE cells yielding pathological lymph node metastasis in papillary thyroid cancer.

Xiao G, Xie R, Gu J, Huang Y, Ding M, Shen D Clin Transl Med. 2025; 15(1):e70172.

PMID: 39810624 PMC: 11733439. DOI: 10.1002/ctm2.70172.


The Role of Non-coding RNAs in Tumorigenesis, Diagnosis/Prognosis, and Therapeutic Strategies for Cutaneous Melanoma.

Schaft N, Dorrie J Methods Mol Biol. 2024; 2883:79-107.

PMID: 39702705 DOI: 10.1007/978-1-0716-4290-0_4.


A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor.

Mei W, Faraj Tabrizi S, Godina C, Lovisa A, Isaksson K, Jernstrom H Cell. 2024; 188(2):371-389.e28.

PMID: 39657676 PMC: 11770377. DOI: 10.1016/j.cell.2024.11.009.


Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?.

Zou J, Xu B, Luo P, Chen T, Duan H Front Immunol. 2024; 15:1482765.

PMID: 39628486 PMC: 11611751. DOI: 10.3389/fimmu.2024.1482765.


References
1.
Hurst D, Edmonds M, Welch D . Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res. 2009; 69(19):7495-8. PMC: 2756311. DOI: 10.1158/0008-5472.CAN-09-2111. View

2.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

3.
Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam B . The gene expression signatures of melanoma progression. Proc Natl Acad Sci U S A. 2005; 102(17):6092-7. PMC: 1087936. DOI: 10.1073/pnas.0501564102. View

4.
Chapman P, Hauschild A, Robert C, Haanen J, Ascierto P, Larkin J . Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011; 364(26):2507-16. PMC: 3549296. DOI: 10.1056/NEJMoa1103782. View

5.
Wang Y, Klijn J, Zhang Y, Sieuwerts A, Look M, Yang F . Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005; 365(9460):671-9. DOI: 10.1016/S0140-6736(05)17947-1. View